Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
Author(s) -
Paul R. Graves,
Lucas J. AponteCollazo,
Emily M.J. Fennell,
Adam C. Graves,
Andrew Hale,
Nedyalka Dicheva,
Laura E. Herring,
Thomas S.K. Gilbert,
Michael P. East,
Ian M. McDonald,
Matthew R. Lockett,
Hani Ashamalla,
Nathaniel J. Moorman,
Donald S. Karanewsky,
Edwin J. Iwanowicz,
Ekhson Holmuhamedov,
Lee M. Graves
Publication year - 2022
Publication title -
acs chemical biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.899
H-Index - 111
eISSN - 1554-8937
pISSN - 1554-8929
DOI - 10.1021/acschembio.2c00545
Subject(s) - protease , chemistry , anticancer drug , computational biology , biochemistry , combinatorial chemistry , pharmacology , biology , enzyme , drug
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom